Does TELMISARTAN Cause Lung neoplasm malignant? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Lung neoplasm malignant have been filed in association with TELMISARTAN (telmisartan). This represents 0.2% of all adverse event reports for TELMISARTAN.
13
Reports of Lung neoplasm malignant with TELMISARTAN
0.2%
of all TELMISARTAN reports
2
Deaths
7
Hospitalizations
How Dangerous Is Lung neoplasm malignant From TELMISARTAN?
Of the 13 reports, 2 (15.4%) resulted in death, 7 (53.8%) required hospitalization, and 1 (7.7%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which TELMISARTAN Alternatives Have Lower Lung neoplasm malignant Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS